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HIV-1, like the other lentiviruses, has evolved the ability to infect nondividing cells including 
macrophages. HIV-1 replication in monocytes/macrophages entails peculiar features and 
differs in many respects from that in CD4 T lymphocytes. HIV-1 exhibits different tropism 
for CD4 T cells and macrophages. The virus can enter macrophages via several routes. 
Mitosis is not required for nuclear import of viral DNA or for its integration into the host cell 
genome. Specific cellular factors are required for HIV-1 transcription in macrophages. The 
assembly and budding of viral particles in macrophages take place in late endosomal 
compartments. Viral particles can use the exosome pathway to exit cells. Given their 
functions in host defence against pathogens and the regulation of the immune response plus 
their permissivity to HIV-1 infection, monocytes/macrophages exert a dual role in HIV 
infection. They contribute to the establishment and persistence of HIV-1 infection, and may 
activate surrounding T cells favouring their infection. Furthermore, monocytes/macrophages 
act as a Trojan horse to transmit HIV-1 to the central nervous system. They also exhibit 
antiviral activity and express many molecules that inhibit HIV-1 replication. Activated 
microglia and macrophages may also exert a neurotrophic and neuroprotective effect on 
infected brain regulating glutamate metabolism or by secretion of neurotrophins. This review 
will discuss specific aspects of viral replication in monocytes/macrophages and the role of 
their interactions with the cellular environment in HIV-1 infection swinging between 




Lentiviruses can infect and replicate in non-dividing cells, including cells of the 
monocyte/macrophage lineage. Some non-primate lentiviruses, such as caprine arthritis and 
encephalitis virus (CAEV) and Maedi-Visna virus, which cause chronic inflammatory 
diseases, exhibit a restricted tropism for monocytes/macrophages. Conversely, lentiviruses, 
such as the feline, simian and human immunodeficiency viruses (FIV, SIV and HIV, 
respectively), have acquired a wider tropism and an expanded range of target cells, primarily 
CD4+ T lymphocytes. Lentiviruses may cause CD4+ T cell depletion and immunodeficiency. 
The capacity of lentiviruses to infect macrophages and other antigen-presenting cells (APC) 
plays a determinant role in the establishment, persistence and pathogenesis of infection. 
Macrophages greatly contribute to innate responses to pathogens, and are at the interface 
between innate and adaptive immunity. Thus, they play a central role in defence and in the 
control of infections, either by directly destroying invading pathogens or by secreting 
cytokines able to inhibit their replication or to activate other arms of the innate or adaptive 
immune responses. The infection of macrophages by intracellular pathogens, including 
lentiviruses, may impair their functions and alter the cytokine production pattern, resulting in 
chronic inflammation and tissue damage. Unlike T cells, HIV-infected macrophages appear to 
be resistant to the cytopathic effects of the virus and thus serve as a reservoir for persistent 
infection. The capacity of monocytes and macrophages to migrate in organs and to survive in 
tissues makes them potential conveyors of HIV-1 infection. Their interplay, as APCs or a 
source of chemotactic cytokines, with CD4 T cells may favour intercell virus transmission. 
Therefore, monocytes/macrophages are thought to play an ambiguous, dichotomous role in 
lentiviral infections, acting either as an antiviral defence system or a virus target, a host cell 
guardian or a Trojan horse (Herbein et al., 2002). There is increasing interest in several 
aspects of macrophage infection by HIV, including the mechanisms of HIV replication in 
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monocytes/macrophages, and the roles of these cells in the control of the infection, the 
pathogenesis of disease and viral escape from antiretroviral therapy. A considerable number 
of recent reviews have addressed many of these points (Freedman et al., 2003; Gras et al., 
2003; Kedzierska et al., 2003a; Kedzierska et al., 2003b) and articles contained in the special 
issue of November 2003 of J. Leukoc. Biol., n° 74). Thus, this review will summarise current 
knowledge of some characteristics of HIV infection of macrophages: a) peculiar features of 
HIV replication in macrophages, including viral entry, nuclear import of viral DNA, and virus 
assembly and release, b) interactions of HIV-1-infected macrophages with the cellular 
environment, c) the molecular interactions of brain macrophages with the central nervous 
system in HIV infection and d) the range of inhibitory activities exerted by macrophages on 
HIV replication. 
Peculiar features of HIV-1 replication in macrophages.  
The HIV-1 life cycle in macrophages differs in many respects from that in CD4 T 
lymphocytes (Fig. 1). Indeed, different HIV-1 isolates show different tropism for CD4 T cells 
and macrophages (Cheng-Mayer et al., 1988; Fenyö et al., 1988; Wu et al., 1997). Unlike T 
cells, productive HIV-1 infection occurs independently of cellular DNA synthesis in 
macrophages (Weinberg et al., 1991). The assembly and budding of viral particles take place 
in cytoplasmic vacuoles in macrophages but not in T cells (Orenstein et al., 1988). 
Furthermore, HIV-1 accessory genes may have distinct effects in primary macrophages and 
lymphocytes (Sherman et al., 2002; Subbramanian et al., 1998; Swingler et al., 2003). Some 
cellular factors required for HIV-1 transcription, such as GATA-3, ETS-1, LEF-1 and NF-
ATc, are lymphoid or T cell-specific (Kinoshita et al., 1997; Yang and Engel, 1993), whereas 
others, such as CCAAT/enhancer binding protein  (C/EBP, are necessary for HIV-1 
replication in macrophages but not in T cells (Henderson and Calame, 1997; Lee et al., 2002). 
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HIV-1 entry in human macrophages 
In recent years, there has been much debate regarding the ability of HIV-1 strains 
that use CXCR4 as a co-receptor to enter target cells (X4 viruses) to infect macrophages. 
Indeed, although CXCR4 is expressed in both monocytes and mature macrophages (Naif et 
al., 1998; Valentin et al., 2000; Verani et al., 1998), it is unclear whether X4 viruses can 
productively infect macrophages. It is generally agreed that most T-cell line-adapted 
laboratory (TCLA) strains of HIV-1, such as the IIIB strain, infect macrophages at best 
inefficiently. However, conflicting results have been obtained about primary isolates. In 
particular, some authors observed that macrophages are refractory to X4 HIV-1 isolates (Yi 
et al., 1998), whereas others found that X4 strains can efficiently enter macrophages but 
subsequently remain blocked at a post-entry level (Schmidtmayerova et al., 1998). In 
contrast, several groups have reported that primary isolates that use CXCR4 can enter 
macrophages and replicate efficiently (Simmons et al., 1998; Valentin et al., 2000; Verani et 
al., 1998). This is supported by the rigorous demonstration that all the relevant viral isolates 
are selective CXCR4 users, by the demonstration that CXCR4 is functional in an 
independent assay (i.e., chemotaxis), and most importantly, by the ability of different 
ligands for CXCR4, including stromal cell-derived factor (SDF)-1, anti-CXCR4 mAb and 
the bicyclam derivative AMD3100, to prevent HIV-1 infection. Finally, an HIV-1 primary 
strain isolated from the central nervous system of an individual with AIDS that is restricted 
to CXCR4 and induced neuronal apoptosis was reported to replicate efficiently in 
macrophages (Yi et al., 2003). 
The abovementioned discrepancies were probably caused by differences in experimental 
conditions, such as macrophage isolation and culture methods, assays for measuring co-
receptor function or HIV-1 infection, and temporal modulation of CD4 and CXCR4 levels 
during cell culture. Indeed, the capacity of X4 strains to replicate in macrophages depends 
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largely on how these cells were cultured; different culture conditions may produce 
macrophages at different stages of activation, which affects the pattern of molecules 
expressed on the cell surface including proteoglycans and, most importantly, the profile of 
released cytokines and chemokines (Bakri et al., 2001).  
However, peculiar molecular features also contribute to differences between X4 and R5 
HIV-1 replication in macrophages. Indeed, western blot analysis of surface proteins from 
monocytes, macrophages and T cells demonstrated differences in the biochemical properties 
of CXCR4 molecules in different cell types. CXCR4 was found to be mainly a monomer in 
monocytes and T cells, but was principally a species of higher molecular weight on the 
surface of macrophages (Lapham et al., 1999). CD4 co-precipitated with CXCR4 monomers 
but not with the high molecular weight form, suggesting that this CXCR4 form cannot 
associate with CD4 (Lapham et al., 1999). In addition, CCR5 and CXCR4 interfere with 
each other during viral fusion and entry (Lee et al., 2000). This interference is due to 
competition for limiting CD4 molecules. Interestingly, in cells with low surface density of 
CD4, co-expression of CCR5 and CXCR4 significantly reduces their susceptibility to 
infection with X4 viruses (Lee et al., 2000).  
Horizontal transmission of X4
 
HIV-1 is believed to occur very rarely. Indeed, examination of 
the phenotypes of HIV-1 strains sampled at different times during the course of infection 
revealed that recently infected individuals predominantly harbour R5 isolates (Koot et al., 
1996; Zhang et al., 1998). Moreover, selective suppression of X4 viruses has been reported in 
some cases of in vivo transmission of a heterogeneous HIV-1 population (Cornelissen et al., 
1995). Furthermore, individuals homozygous for a 32-bp deletion in the CCR5 gene, which 
abrogates CCR5 expression, are resistant to HIV-1 infection (Samson et al., 1996). These 
observations emphasise the pivotal and unique role of CCR5 in the in vivo transmission of 
HIV-1 and imply the existence of negative selective forces acting against X4 variants, the 
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nature of which is still unknown. The observations that CXCR4 is expressed on macrophages 
and mediates the cell-free entry of X4 viruses rule out the possibility that this co-receptor is 
not available in cells that act as initial targets for infection, such as mucosal macrophages or 
Langerhans cells, and suggest that other types of antiviral mechanism selectively target X4 
variants. The CXCR4 ligand, SDF-1, is a suitable candidate as it is constitutively and strongly 
expressed in the epithelium of the genital mucosa, which could favour the preferential 
transmission of R5 isolates in this zone (Agace et al., 2000). 
Although HIV-1 enters target macrophages mainly by the binding of the viral glycoprotein 
gp120 to CD4 and a chemokine coreceptor and fusion with the cell membrane, electron 
microscopy revealed virions in several locations shortly after viral exposure (Maréchal, 
2001). This suggested the existence of alternative entry routes. Macropinocytosis has been 
shown to be involved in the entry of HIV-1 into macrophages (Maréchal, 2001). 
Macropinocytosis is an endocytic process that does not require any binding at the cell 
surface, as the extracellular fluid is engulfed by cellular ruffles (Amyere et al., 2002). 
Shortly after exposure of macrophages to HIV-1, and irrespective of gp120-receptor 
interactions, viral particles are visible in intracellular vesicles named macropinosomes. Most 
virions are subsequently degraded. However, a fraction of the virions that are internalised 
by intracellular vesicles escapes destruction and leads to productive infection (Maréchal, 
2001). Virions can also interact with macrophages in several other ways. Various molecules 
expressed on cell surface bind the virus without leading to productive infection. These 
molecules concentrate virus particles on the target cell surface or transfer the virus to CD4
+
 
cells. Receptors for the Fc portion of immunoglobulins or for complement are involved in 
the entry and infection of macrophages by antibody and complement opsonized viruses 
(reviewed in (Montefiori, 1997). Initial virus-cell interactions may involve non-specific 
binding of gp120 with cell surface heparan sulphate proteoglycans (Mondor et al., 1998; 
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Roderiquez et al., 1995; Saphire et al., 2001). The carbohydrate moieties of gp120 may also 
play an important role. In this context, dendritic cell-specific intercellular adhesion 
molecule (ICAM)-3 grabbing non-integrin (DC-SIGN), a C-type lectin specifically 
expressed by dendritic cells (DC), mediates the capture and transmission of HIV-1 from DC 
to CD4
+
 T cells (Geijtenbeek et al., 2000). DC-SIGN-bound virus is more infectious and has 
a longer half-life than free virus. As DC-SIGN mediates the binding of R5 and X4 strains of 
HIV-1, HIV-2 and SIV, it may function as a general lentiviral attachment factor (Baribaud 
et al., 2001; Geijtenbeek et al., 2000). However, despite the marked up-regulation of DC-
SIGN by type 1 (IFN-) and type 2 cytokines (IL-4 and IL-13) in macrophages, no 
association was observed between DC-SIGN expression and the amount of HIV-1 
transmission to CD4
+
 T cells (Chehimi et al., 2003). Furthermore, there is evidence 
suggesting that DC-SIGN is not the only adhesion molecule that can bind and transmit HIV. 
It was recently suggested that additional C-type lectin receptors play a role (Turville et al., 
2003). In particular, as about half of the carbohydrates on gp120 are terminally 
mannosylated, the role of the macrophage mannose receptor (MMR) on primary 
macrophages has been investigated (Nguyen and Hildreth, 2003). The MMR is an innate 
immune receptor expressed on macrophages and DC, the function of which is to recognise 
patterns of terminal mannosylation on foreign particles (Stahl and Ezekowitz, 1998). 
Approximately 60% of the initial association of HIV with macrophages is mediated by 
MMR, as evidenced by the inhibitory effect of mannan, D-mannose and soluble mannose-
binding lectin, but not D-galactose. Moreover, macrophages are able to mediate the 
transmission of bound HIV to co-cultured T cells and up to 80% of this transmission is 
blocked by inhibitors of MMR binding (Nguyen and Hildreth, 2003). 
It is important to identify the attachment factors on DC and macrophages. DC in the mucosal 
epithelium and macrophages located in the submucosal tissues may be initial targets for HIV-
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1. Thus, these data further suggest that the capture of HIV in these zones and the subsequent 
transport of infectious viral particles by DC and macrophages to the lymph nodes, where virus 
replication can be amplified, could strongly facilitate virus dissemination. 
Nuclear import 
The capacity to replicate in non-dividing cells is a specific feature that distinguishes 
lentiviruses from murine and avian retroviruses, which require nuclear membrane breakdown 
during mitosis for viral cDNA integration (Lewis et al., 1992; Roe et al., 1993). Some studies 
have suggested that only macrophages that maintain proliferative capacity can support 
productive HIV-1 infection (Kootstra and Schuitemaker, 1998; Schuitemaker et al., 1994). 
This was attributed to the need for cellular activation to complete the reverse transcription. 
However, mitosis is not required for HIV-1 provirus integration in macrophages or for the 
establishment of productive infection (Schuitemaker et al., 1994). Nevertheless, integration of 
viral DNA requires access to chromosomal DNA. In non-dividing cells, a large nucleoprotein 
complex, the preintegration complex (PIC), which contains the linear viral DNA and the viral 
and cellular proteins needed for integration, must pass through nuclear pores to reach the 
nucleus (Miller et al., 1997). HIV-1 PIC was first suggested to have a diameter of 56 nm. 
However, more recent studies suggested that it is even larger (McDonald et al., 2002; Nermut 
and Fassati, 2003), even though the nuclear pore channel allows the passage of smaller 
molecules (<40-45 kDa). PIC is transported through nuclear pores via an active, energy-
dependent mechanism (Bukrinsky et al., 1992; Depienne et al., 2001; Gallay et al., 1997). 
This property of lentiviruses has major consequences in the establishment of infection and in 
pathogenesis, and has been exploited to generate vectors for the delivery of genes to non-
dividing cells. However, the ability of lentiviral vectors to transduce monocytes or 
macrophages can differ, suggesting that nuclear import efficiency varies with cell 
differentiation and/or activation. Neil et al. reported that an HIV-1-derived vector remained 
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blocked at the level of nuclear translocation in freshly isolated monocytes, but not in 
macrophages (Neil et al., 2001). HIV-1 nuclear import is down-regulated in 
lipopolysaccharide (LPS)-stimulated monocyte-derived macrophages, due to the activation of 
p38 kinase (Zybarth, 1999). Despite numerous studies, the factors involved in the nuclear 
transport of the lentiviral PIC and the underlying mechanisms are still unclear and a matter of 
debate.  
After reaching the cytoplasm of the infected cell, HIV-1 reverse transcription takes place in 
the reverse transcription complex (RTC), constituted by virion core proteins, cellular proteins 
and the RNA genome (McDonald et al., 2002; Nermut and Fassati, 2003). Following the 
completion of DNA synthesis, the RTC matures in the PIC. The double-stranded viral DNA is 
synthesised within a few hours in T cells but is slower (36 to 48 h) in macrophages, for 
unknown reasons (Collin et al., 1994; O'Brien et al., 1994). RTCs migrate towards the 
nucleus, probably by using cellular motors, such as dynein, to move along the cell 
cytoskeleton (Bukrinskaya et al., 1998; McDonald et al., 2002). At the nuclear membrane, the 
viral DNA assembled in the PIC has to deal with nuclear pore complexes before it can reach 
the nucleus. A peculiar feature of the lentiviral genome, the central DNA flap, is involved in 
the nuclear import of PIC. The central DNA flap is a stretch of triple-stranded DNA that is 
formed due to the presence in lentiviruses of two initiation sites for the plus strand DNA 
synthesis, the 3’ terminal and the central polypurine tracts (PPT). During the plus strand DNA 
synthesis, the two nascent DNA fragments overlap at the central PPT (cPPT) region. In HIV-
1, the central DNA flap is a 99-nucleotide overlap. This structure enhances the nuclear import 
of the PIC, increasing the transduction efficiency of lentiviral vectors (Sirven et al., 2000; 
Zennou et al., 2000). The increased efficiency of cPPT-containing vectors has been attributed 
at least in part to enhanced nuclear import (Van Maele et al., 2003; Zennou et al., 2000). 
However, some studies have shown that cPPT mutant HIV-1 can replicate in non-dividing 
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cells including primary macrophages, albeit less efficiently than the parental virus (Dvorin et 
al., 2002; Limon et al., 2002b).  
Viral proteins are also involved in the nuclear transport of HIV-1 PIC (Fouchier and Malim, 
1999). HIV integrase (IN) and matrix (MA) proteins carry sequences that may serve as 
nuclear localisation signals (NLS) for the recognition and targeting of the PIC to the nuclear 
pore by the importin-/ pathway (Gallay et al., 1997; Gallay et al., 1996). However, IN NLS 
mutants cannot replicate in either dividing and non-dividing cells, suggesting that IN NLS is 
involved in steps of replication other than nuclear import (Limon et al., 2002a; Petit et al., 
2000; Tsurutani et al., 2000). IN has intrinsic karyophilic properties and may play a key role 
in nuclear import, independent of NLS (Bouyac-Bertoia et al., 2001; Depienne et al., 2001; 
Devroe et al., 2003). HIV-1 MA contains two sequences that could act as an NLS (Bukrinsky 
et al., 1993; Haffar et al., 2000). MA NLS mutants were found to be unable to replicate in 
macrophages in some studies but not in others (Fouchier et al., 1997; Reil et al., 1998; von 
Schwedler et al., 1994). The third viral protein involved in nuclear import of HIV-1 PIC is the 
viral protein R (Vpr) (Heinzinger et al., 1994; Popov et al., 1998) which is present only in 
lentiviruses. Vpr contains two non-canonical NLS that may contribute to nuclear transport of 
the PIC (Jenkins et al., 1998), and interacts with cellular import machinery through importin 
 and the nucleoporins (Popov et al., 1998; Vodicka et al., 1998). A study based on the 
overexpression of Vpr has suggested that PIC enters the nucleus by inducing herniations and 
partial breaking of the nuclear envelope (de Noronha et al., 2001). However, the role of Vpr 
in the nuclear import of PIC in macrophages is still controversial (Bouyac-Bertoia et al., 
2001; Gallay et al., 1997). Vpr and MA may cooperate for the nuclear import of the PIC 
(Haffar et al., 2000; Popov et al., 1998). However, viruses lacking MA NLS and Vpr 
(Vpr.NLS) are able to replicate in macrophages, albeit less efficiently than the wild-type 
virus (Fouchier et al., 1997; Kootstra and Schuitemaker, 1999). This suggests that Vpr and 
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MA-NLS are not essential for HIV-1 replication in primary macrophages. Nevertheless, 
several studies have suggested that Vpr confers an advantage for HIV replication in 
macrophages (Balliet et al., 1994; Connor et al., 1995). A Vpr-deficient R5 virus efficiently 
infected T lymphocytes in tonsil cell cultures, but was severely affected in its ability to infect 
macrophages (Eckstein et al., 2001). This was potentially explained in recent experiments 
using a Vpr mutant that does not affect nuclear import but that impairs the nuclear export of 
Vpr and its incorporation into virions. The efficient nuclear export of Vpr enhances viral 
replication in cultured macrophages (Sherman et al., 2003). HIV-2 and SIV contain two 
related genes, vpr and vpx. In these viruses, Vpx performs the functions of HIV-1 Vpr 
associated with replication in macrophages and nuclear targeting (Fletcher et al., 1996). It is 
noteworthy that a Vpx mutant SIV that was unable to replicate in macrophages did not 
disseminate in infected macaques and did not cause disease (Hirsch et al., 1998). 
The cellular machinery required for the nuclear import of proteins is also involved in HIV-1 
PIC import (Fouchier et al., 1998; Gallay et al., 1997; Gallay et al., 1996; Vodicka et al., 
1998). However, it is not clear whether nuclear import receptors (karyopherins or importins) 
are required for the nuclear transport of IN: the nuclear accumulation of IN has been shown to 
be independent of importins and of the associated GTPase Ran activity (Depienne et al., 
2001). Using purified PIC, Fassati et al. have recently reported that importin 7, a member of 
the importin  superfamily, plays an important role in the nuclear import of HIV-1 PIC 
(Fassati et al., 2003). Competition with the histone H1, which binds the imp7-impb 
heterodimer, blocks nuclear import of HIV-1 PIC in primary macrophages. Suppression of 
imp7 by siRNA reduces HIV-1 infection of HeLa cells. Fassati et al. propose that imp7 
mediates nuclear import through the NPC after binding to IN and/or other basic viral proteins 
in the PIC (Fassati et al., 2003). 
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Finally, nuclear import and integration of HIV-1 vectors can also occur independently of 
mitosis in cycling cells (HeLa) (Katz et al., 2003). If confirmed in natural target cells, such as 
CD4+ T cells, this would suggest that a biological feature of lentiviruses that allows infection 
of non-dividing cells without the need for mitosis-dependent integration could also favour 
HIV-1 replication in cycling cells. 
Viral transcription in macrophages 
HIV-1 transcription is differentially regulated in macrophages and in T cells (reviewed in 
(Rohr et al., 2003)). Transcriptional modulation of HIV-1 replication in 
monocytes/macrophages has been related to the expression of different isoforms of the 
transcription factor C/EBP. Different isoforms of C/EBPare generated by alternative 
translational initiation. The 30-37-kDa activating isoform is required for HIV replication in 
monocytes/macrophages but not in CD4+ T lymphocytes (Henderson and Calame, 1997). 
Conversely, the small (16-23-kDa) isoform is dominant negative and its induction by INF- 
in differentiated THP-1 macrophages inhibits HIV-1 transcription (Honda et al., 1998). 
Mycobacterium tuberculosis or LPS also induce the expression of the inhibitory 
C/EBPisoform, possibly through INF-induction and inhibit HIV-1 replication (Honda et 
al., 1998; Weiden et al., 2000). GM-CSF treatment during the differentiation of monocytes 
into macrophages strongly decreases the susceptibility of macrophages to R5 viruses in 
comparison with macrophages differentiated in the presence of M-CSF. Viral suppression in 
GM-CSF-induced macrophages is related to the expression of the inhibitory C/EBPisoform 
(Komuro et al., 2003). Treatment of GM-CSF-induced macrophages with antisense 
oligonucleotides for C/EBPdecreases the amount of the inhibitory isoform produced and 
increases HIV-1 production (Komuro et al., 2003). This study also showed the inverse 
regulation of the Src-like tyrosine kinase Hck and suggested that the heterogeneity in 
macrophage susceptibility to HIV-1 infection was related to distinct regulation of Hck and the 
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inhibitory isoform of C/EBPGM-CSF-induced macrophages present similar morphological 
and functional features to alveolar macrophages (Komuro et al., 2001). The low level of 
susceptibility of alveolar macrophages to HIV-1 infection may be related to the expression of 
the dominant inhibitory C/EBPisoform (Honda et al., 1998). Activated allogeneic 
lymphocytes reduce the expression of the C/EBP isoform in differentiated THP-1 and 
alveolar macrophages, increasing susceptibility to HIV-1 (Hoshino et al., 2002). This 
mechanism may operate in pathological conditions such as tuberculosis, which causes 
inflammation of the lungs (Orenstein et al., 1997). 
Virus assembly and release 
New virions are generated by the assembly of HIV genomic RNA and viral proteins, and by 
the release of viral particles by budding from the infected cell. This process is promoted and 
regulated by the Gag polyprotein, which is targeted to membranes by the myristylated NH2-
terminus of MA (Freed, 1998). Viral components are assembled in late 
endosomes/multivescicular bodies (MVB) in macrophages (Pelchen-Matthews et al., 2003; 
Raposo et al., 2002). Gag targeting and HIV-1 assembly have been suggested to occur in late 
MVB in macrophages and in other cells including CD4+ T lymphocytes (Nydegger et al., 
2003). However, other authors suggested that the targeting of Gag to the plasma membrane in 
T cells or to MVB in macrophages involves different signals (Ono and Freed, 2004). In T 
cells and HeLa cells, mutations in MA retarget HIV-1 Gag from the plasma membrane to 
MVB. In contrast, in macrophages, both MA mutants and wild-type viruses are targeted to 
MVB (Ono and Freed, 2004). Gag drives HIV-1 budding through the Gag p6 late domain (L 
domain). L domain binds the tumour susceptibility gene 101 (TSG101), hijacking the host’s 
MVB vesicle formation machinery, and recruits proteins of the ESCRT (endosomal sorting 
complexes required for transport) family, which regulate MVB biogenesis and cellular 
vacuolar protein sorting pathways (Pornillos et al., 2003; Strack et al., 2003; von Schwedler et 
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al., 2003). The release of HIV-1 also seems to differ in T cells and in macrophages. In T cells, 
the nascent HIV-1 particle buds from the cell membrane at the sites of cholesterol- and 
sphingolipid-rich regions known as lipid rafts (Esser et al., 2001; Nguyen and Hildreth, 2000). 
Late endosomes also fuse to the plasma membrane and may release virus particles into the 
external medium (Nydegger et al., 2003). In macrophages, viruses can also bud to the lumen 
of endocytic organelles (Pelchen-Matthews et al., 2003). It has long been known that HIV-1 
particles accumulate in intracellular vacuoles in macrophages (Orenstein et al., 1988). Recent 
studies using immuno-electron microscopy identified these vacuoles as the major 
histocompatibility complex class II (MHC class II) late endocytic compartment (Raposo et al., 
2002). A combination of immuno-ultrastructural studies on HIV-1-infected macrophages and 
biochemical analysis of the released virions confirmed that the virus-containing compartments 
have markers and topology consistent with late endosomes or MVBs, and that the viral 
membrane contains late endosomal proteins (Pelchen-Matthews et al., 2003). MVBs contain 
intraluminal vescicles that can be released as exosomes from the cell by fusion of MVB with 
the plasma membrane. According to the Trojan exosome hypothesis (Gould et al., 2003), 
HIV-1 (and other retroviruses) exits infected cells via the exosome pathway. 
Immunochemical studies showed that infectious viruses released from macrophages contain 
low amounts of cell surface markers and lack some lipid-raft-associated proteins, such as 
CD14, but share similar protein patterns with macrophage-derived exosomes (CD63, MHC 
class II, Lamp 1) (Nguyen et al., 2003; Pelchen-Matthews et al., 2003; Raposo et al., 2002). 
These data are consistent with previous studies showing different markers in macrophage- and 
T cell-derived viruses (Esser et al., 2001; Frank et al., 1996) and suggest that HIV-1 budding 
and release differ in macrophages and in T cells. The differential inclusion of cellular proteins 
in viral particles may be relevant for virus transmission and replication. The CD63 molecule 
may be involved in R5 HIV-1 infection of macrophages but not of T cells (von Lindern et al., 
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2003). In macrophages, budding into endosomes may render the virus inaccessible to antiviral 
inhibitors, including RNAi, and enable the virus to persist in macrophages, which function as 
viral reservoirs. Viral exosomes may further escape immune surveillance during cell to cell 
transmission (Gould et al., 2003). 
Interactions between macrophages and the cellular environment in HIV-1 infection 
Functional defects in HIV-1-infected macrophages 
 
Functionally defective monocytes have been described in HIV-1-infected individuals 
for many years (Miedema et al., 1988). Monocyte/macrophage functions that are essential for 
adequate innate and adaptive responses to pathogens, such as antigen presentation, 
intracellular pathogen killing or phagocytosis, are affected by HIV-1 infection (Biggs et al., 
1995; Kumar et al., 1999; Polyak et al., 1997; Yoo et al., 1996); revewed in (Kedzierska et al., 
2003a). Phagocytosis is mediated by a number of phagocytic receptors expressed on 
monocytes/macrophages, including complement receptors (CR) and receptors for the Fc 
portion of immunoglobulins (FcR) (Aderem and Underhill, 1999). CR and FcR mediate 
phagocytosis of pathogens opsonised with antibodies and complement. FcRs that are able to 
induce phagocytosis in human macrophages include FcRI, FcRIIA and FcRIII. FcR 
aggregate after binding to immune complexes, this induces signalling through the 
phosphorylation of a cytoplasmic activating motif (immunoglobulin gene family tyrosine 
activation motif, ITAM). FcRIIA bears an ITAM in its intracytoplasmatic tail, whereas 
FcRI and FcRIII associate with  subunits containing ITAMs. Kedzierska et al. recently 
showed that HIV-1 infection of macrophages at a high m.o.i. affects FcR-mediated 
phagocytosis by inhibiting the phosphorylation of Src kinases and other proteins involved in 
the early steps of FcR signalling, such as Hck, Syk and paxillin (Kedzierska et al., 2002). 
This defect was attributed to the down-regulation of the intracytoplasmic expression of the  
signalling subunit, probably at the posttranscriptional level (Kedzierska et al., 2002). 
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Surprisingly, the defect of  subunit expression did not alter the surface expression of FcRs 
in HIV-1-infected macrophages. Defective phagocytosis and  chain down-regulation are 
independent of Nef expression (Kedzierska et al., 2002; Kedzierska et al., 2001). 
HIV-1 infection in macrophages results in impaired FcR signalling and phagocytosis, 
whereas macrophage stimulation through FcRs potently inhibits HIV-1 replication (Perez-
Bercoff et al., 2003). To determine the effect of FcR-mediated stimulation by immune 
complexes on HIV-1 infection, monocyte-derived macrophages were exposed to human IgG 
immobilised on culture plates. FcR cross-linking by immobilised hIgG suppresses the 
replication of both R5 and X4 strains of HIV-1. Although FcR cross-linking by immobilised 
IgG induces the secretion of several cytokines and chemokines, including tumour necrosis 
factor  (TNF-, macrophage colony-stimulating factor (M-CSF) and macrophage-derived 
chemokine (MDC), HIV-1 suppression is not dependent on the soluble factors released into 
culture supernatants. Neither HIV-1 entry nor reverse transcription appear to be affected in 
FcR-stimulated macrophages. In contrast, PCR signals for integrated proviral DNA were 
weaker and 2-LTR signals were stronger, indicating a restriction of viral integration in the 
host genome (Perez-Bercoff et al., 2003)Aggregation of the activator receptors FcRI, 
FcRIIA and FcRIII on macrophage surface by specific Fab or (Fab’)2 cross-linking also 
inhibits HIV-1 replication (David et al., 2003). Circulating immune complexes (CIC) may be 
abundant in chronic infections, which are common in developing countries where HIV/AIDS 
is highly prevalent. Moreover, since the very beginning of the AIDS pandemic it has been 
known that the levels of circulating immune complexes (including HIV-specific CIC) are 
elevated in HIV-positive patients, independent of other infections  (Carini et al., 1987; Tausk 
et al., 1986). HIV-1 immune complexes may, however, facilitate HIV-1 entry through FcRs or 
complement receptors (Homsy, 1989; Takeda et al., 1990). Thus, the stimulation of 
 18 
monocytes and resident macrophages by immune complexes through FcR might modulate 
HIV-1 infection and spread in opposite directions. 
Macrophage-T cell interplay and HIV-1 activation 
HIV-1 infection differentially activates T cells and macrophages. In macrophages, 
early activation is due both to gp120 signalling through CD4 and CCR5 molecules at viral 
entry and to activation of innate defence mechanisms (cytokines, chemokines, proteases) 
(Freedman et al., 2003; Lee et al., 2003; Wahl et al., 2003). After a quiescent phase of a few 
days, viral replication results in further changes in gene expression (Wahl et al., 2003). HIV-
1-infected macrophages can interact with other immune system cells, including CD4+ and 
CD8+ T lymphocytes, resulting in either cell activation or death by apoptosis (recent reviews 
in (Herbein et al., 2002; Mahlknecht and Herbein, 2001). Among the viral proteins implicated 
in macrophage activation, Nef appears to play a prominent role. Nef is a 27-kDa protein that 
is produced early during infection and exerts multiple functional activities. The expression of 
Nef induces the secretion of CC-chemokines MIP-1 and MIP-1 by infected macrophages 
(Swingler et al., 1999). These chemokines may help to recruit T lymphocytes at the site of 
infection by chemotaxis. Moreover, T lymphocytes are activated by a soluble factor released 
by Nef-expressing macrophages, favouring HIV-1 replication (Swingler et al., 1999). Further 
studies by the same laboratory showed that CD40L stimulation of macrophages also leads to 
the release of a factor that induces T lymphocytes to support the replication of an X4 strain of 
HIV-1 without any other extrinsic stimulation (Swingler et al., 2003). Both Nef and the 
CD40L-dependent ability to induce T cell permissivity to HIV-1 is blocked by inhibiting NF-
B activation in macrophages. Indeed, T cell activation is mediated by B lymphocytes 
through the CD22, CD54 CD58 and CD80/CD86 receptors induced by Nef-expressing 
macrophage supernatants. Cross-linking experiments suggested that T cells are stimulated by 
the interaction of the CD22 and CD58 ligands, CD45 and CD2, and that CD54 increased the 
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stimulatory effect by interacting with the CD11a/CD18 integrin. Ligation of the CD80/CD86 
ligand, CD28, induces T cells to enter the cell cycle, which in turn allows productive HIV-1 
infection. Two soluble mediators released from Nef-expressing macrophages, sCD23 and 
sICAM, are involved in the induction of the expression of B cell receptors (Swingler et al., 
2003). It was thus proposed that Nef intersects the CD40 signalling pathways in macrophages 
to induce the release of sCD23 and sICAM. Hence, Nef could promote T cell infection by 
activating signals on antigen-presenting cells that activate resting T lymphocytes in lymphoid 
organs (Swingler et al., 2003). Although most studies mainly concerned endogenously 
expressed Nef, some recent reports suggested that exogenous Nef, which is found in the 
serum of AIDS patients at ng levels (Fujii et al., 1996), also contributes to macrophage 
activation. Exogenous Nef can be internalised by macrophages. Exogenous Nef induces the 
expression of genes coding for inflammatory cytokines in monocytic cells and macrophages, 
and the secretion of CC-chemokines, IL-6 and TNF-. The secretion of inflammatory 
chemokines and cytokines is associated with the activation of the transcription factors NF-B 
and AP-1 (Olivetta et al., 2003; Varin et al., 2003). The release of soluble factors, including 
CCL3, induced by exogenous Nef is also involved in the activation of STAT elements 1 and 
3, which may contribute to the deregulation of signalling pathways associated with cell 
survival or the IFN response (Federico et al., 2001; Percario et al., 2003). 
Macrophages express CD40, which binds CD40L (CD145) expressed on activated CD4+ T 
cells and other immune cell types. The CD40/CD40L interaction plays a central role in the 
activation and regulation of immune responses (van Kooten and Banchereau, 2000) 
(Chougnet, 2003). As discussed above, the activation of macrophages through CD40L up-
regulates the expression of co-stimulatory molecules and leads to the production of 
inflammatory cytokines and chemokines that contribute to T cell activation at the site of 
inflammation. As a consequence, the CD40/CD40L interaction can activate X4 HIV-1 
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replication in CD4+ T cells (Chougnet et al., 2001; Kutsch et al., 2003; Swingler et al., 2003). 
Moreover, activation through CD40 also directly stimulates the replication of X4 HIV-1 in 
macrophages (Bakri et al., 2002). Conversely, CD40L stimulation of macrophages prevents 
the replication of R5 strains of HIV-1 (Bakri et al., 2002; Cotter et al., 2001; di Marzio et al., 
2000; Kornbluth et al., 1998). Supernatants from CD40L-activated macrophages also inhibit 
R5 HIV-1 infection of CD4+ T cells and macrophages. The inhibitory activity is associated 
with the secretion of -chemokines and TNF- and with the down-regulation of the surface 
expression of CCR5 and CD4 (Bakri et al., 2002; Cotter et al., 2001; di Marzio et al., 2000; 
Kornbluth et al., 1998). The CD40L-induced secretion of -chemokines is mediated by the 
rapid activation of MAPK signalling pathways (Bakri et al., 2002; Cotter et al., 2001; di 
Marzio et al., 2000; Kornbluth et al., 1998). When monocytes differentiate in the presence of 
CD40L an opposite effect is described, leading to the up-regulation of CD4 and CCR5 and to 
an increase in HIV-1 entry, but not to an increase in total virus production (Bergamini et al., 
2002). Thus, CD40L activation of macrophages may lead to different and even opposite 
outcomes depending on the viral tropism and the cellular environment. Accordingly, the 
CD40/CD40L interaction occurring between macrophages and T lymphocytes at the site of 
infection and in lymphoid organs may either inhibit viral replication in macrophages and 
protect surrounding T cells from R5 strains of HIV-1 or favour the replication of X4 viruses. 
The particular relationships between brain macrophages/microglia, HIV and the central 
nervous system environment: some keys to neurone survival and death in neuro-AIDS. 
The invasion of the brain by HIV probably involves activated monocytes crossing the blood 
brain barrier (BBB) (Fig. 2 A) (Nottet, 1999; Nottet and Gendelman, 1995). 
Monocytes/macrophages may also contribute to neuro-invasion by producting TNF- which 
alters the BBB structure (Fiala et al., 1997), possibly mediated by enhanced local gelatinase 
expression (Johnston et al., 2001; Lévêque et al., 2004). The role of mononuclear phagocytes 
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infected monocytes (Crowe et al., 2003; Fischer-Smith et al., 2001) and the associated 
inflammatory activation that last throughout the course of the disease. Indeed, infiltrating 
macrophages also contribute to the overproduction of -chemokines. These β-chemokines 
keep the invasion going directly through their own protein production (Persidsky et al., 2000) 
and via inflammatory stimulation of astrocytes to high macrophage chemotactic protein-1 
(MCP-1) release (Weiss et al., 1998). 
It is now accepted that infection and activation of macrophages and microglial cells play a key 
role in HIV-induced neurotoxicity. They can act directly through the production of viral 
neurotoxins. However, the main pathway leading to neuronal death involves immune 
activation and the subsequent release of neurotoxic factors. The mechanism of neuronal 
damage is not fully understood but probably involves glutamate-related exotoxicity and 
oxidative stress resulting in neuronal apoptosis (for review, (Kaul et al., 2001). Nevertheless, 
intense microglial activation, mainly thought to be associated with neurotoxin production, 
occurs early in the disease, even in the asymptomatic pre-AIDS stage (An et al., 1996; 
Sinclair et al., 1994), whereas neuronal loss occurs during the end stage of the disease (for 
review, see reference (Everall et al., 1993). This discrepancy may be related to the 
neuroprotective and neurotrophic aspects entailed by microglial activation, provided that 
activated macrophages and microglial cells (AMM) express neurotrophins, high affinity 
glutamate transporters and glutamine synthetase.  
Activated macrophages and microglia express the molecular effectors of the glial 
glutamate-glutamine cycle.  
Since 1995, several groups have demonstrated that primary microglia (Kondo et al., 1995; 
Lopez-Redondo et al., 2000; Nakajima et al., 1998; Noda et al., 1999; Rimaniol et al., 2000; 
Swanson et al., 1997), as well as resident spleen macrophages and monocyte-derived 
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macrophages (MDM) (Rimaniol et al., 2000), express the two main glial high affinity 
glutamate transporters — excitatory amino acid transporter (EAAT)-1 and -2 — when 
activated (Fig. 2, B,C). Macrophages and microglial cells also express glutamine synthetase in 
vitro (Bode et al., 2000)and in SIV infection (Chrétien et al., 2002). Co-expression of EAATs 
and glutamine synthetase is striking, as the neuroprotective and neurotrophic properties of 
astrocytes are associated with the same expression pattern. 
These effectors are not expressed in normal brains (Lehre et al., 1995), and are highly 
dependent on cell activation and differentiation in vitro (Rimaniol et al., 2000). This strongly 
suggests a compensatory mechanism that responds to depressed astrocytic function. Indeed, 
substances released by infected AMM, such as gp120 (Vesce et al., 1997) TNF- (Fine et al., 
1996), PAF (Nishida et al., 1996) and TGF-ß (Chao et al., 1992; Toru-Delbauffe et al., 1990), 
inhibit glutamate uptake by astrocytes and glutamine synthetase activity and induce glutamate 
release (Bezzi et al., 2001). Conversely, TNF- induces EAAT function in differentiating 
monocytes (Rimaniol et al., 2000). 
This expression pattern of glutamate transporters and glutamine synthetase is also found in 
human AIDS and its macaque model. Neuropathological examinations showed that microglia 
and brain macrophages from asymptomatic SIVmac251-infected macaques express EAAT-2 
and GS, whereas those from uninfected animals do not (Chrétien et al., 2002). EAAT-2 is 
expressed in both perivascular macrophages and parenchymal ramified and non-ramified 
microglia. Most perineuronal microglia strongly express EAAT-2 and GS. Likewise, in study 
on 12 HIV-infected humans at different stages of the disease and three HIV-negative controls, 
EAAT-1 expression by AMM increased with the disease stage in the white matter, whereas it 
was strong in perineuronal microglia only in subjects without HIV encephalitis (Vallat-
Decouvelaere et al., 2003). These data are in keeping with the previous finding that AMM 
may express EAATs when glutamate uptake by astrocytes is impaired. Several in vitro studies 
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have shown that EAAT expression and function in astrocytes are reduced by HIV, probably 
due to the effects of inflammatory mediators and viral proteins (Dreyer and Lipton, 1995; 
Fine et al., 1996; Kort, 1998; Patton et al., 2000; Vesce et al., 1997). These findings (Vallat-
Decouvelaere et al., 2003) support the hypothesis that in HIV infection, besides their classical 
neurotoxic properties involving glutamate-related excitotoxicity (Jiang et al., 2001) and 
oxidative stress (Mollace et al., 2001; Shi et al., 1998), activated microglia play a 
counterbalancing neuroprotective role by clearing extracellular glutamate and producing the 
anti-oxidant glutathione (Rimaniol et al., 2000; Rimaniol et al., 2001). 
Neurotrophin expression defines complex interactions between brain macrophages and 
microglia, and the brain environment. 
Brain macrophages and microglia express a variety of neurotrophins and neurotrophin 
receptors (Barouch et al., 2001; Elkabes et al., 1998; Gilad and Gilad, 1995; Miwa et al., 
1997). The expressed repertoire varies with the cell type, the activation state and the location 
in vivo. These molecules interact closely with inflammatory factors. For example, IL-1, 
TNF- and LPS induce or increase the expression of the nerve growth factor (NGF) by 
microglia through a NFB-dependent mechanism (Heese et al., 1998a; Heese et al., 1998b; 
Lindholm et al., 1987; Mallat et al., 1989; Nakajima et al., 2001), whereas the complement 
component C3a has the same effect independently of NFB activation (Heese et al., 1998b). 
Likewise, LPS and C8 ceramide induce microglia to release brain-derived neutrophic factor 
(BDNF), the latter acting even in the absence of tumour necrosis factor  (TNF- (Nakajima 
et al., 2001; Nakajima et al., 2002). Interleukin-1 (IL-1 is a key regulator of ciliary 
neurotrophic factor (CNTF) production by astrocytes (Herx et al., 2000). This trophic factor is 
chemotactic to macrophages (Kobayashi and Mizisin, 2000) and an enhancer of CD4, CR3 
and p75NTR production by microglia (Hagg et al., 1993). The effects of neurotrophins on 
macrophages and microglia are not clearly understood. Nevertheless, NGF has been reported 
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to have anti-inflammatory activities. For example, it can decrease the expression of activation 
molecules (Nakajima et al., 1998; Wei and Jonakait, 1999) and responsiveness to LPS 
(Nakajima et al., 1998). Moreover, the phagocytosis of apoptotic cells by microglia induces 
the already described anti-inflammatory activation profile with prostaglandin E2 (PGE2) and 
transforming growth factor  (TGF induction, as well as the repression of TNF- 
production. This peculiar activation of microglial cells also entails the production of NGF (De 
Simone et al., 2003), suggesting that it has anti-inflammatory properties. 
In HIV-infected patients with neurological impairment (HIV encephalitis and/or AIDS 
dementia complex), activated microglia overproduce BDNF (Soontornniyomkij et al., 1998), 
and NGF is found in excess in perivascular macrophages (Boven et al., 1999). These data 
strongly suggest that AMM produce neurotrophins in the infected brain, thereby limiting 
inflammation and its deleterious effects on neurones. Together with the low level of virus 
replication in the central nervous system (CNS), probably due to the repressive effect of 
astrocytes (Hori et al., 1999; Nottet et al., 1995), this may participate in the lack of neuronal 
death in HIV infection before very late stages. The relationships between AMM and the 
neurotrophin family may also be critical for the establishment and long-term persistence of 
the virus reservoir in the brain. Indeed, HIV infection per se induces NGF expression in 
macrophages (Garaci et al., 1999), leading to an autocrine loop involving NGF and its high 
affinity receptor TrkA for macrophage survival despite massive virus production. This 
survival effect involves bcl2, bcl-xL and bfl1 anti-apoptotic molecules (la Sala et al., 2000) 
and is abrogated by NGF neutralisation leading to p75NTR-mediated apoptosis (Caroleo et 
al., 2001; Garaci et al., 1999). This could be a powerful mechanism for maintaining viral 
replication (Garaci et al., 2003), especially in the restrictive CNS milieu, and illustrates 
exactly how HIV uses endogenous molecules for its own benefit. 
Macrophage antiviral factor, “MAF” 
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It is well-known that CD8
+
 T cells actively contribute to host defences against HIV 
infection via two different mechanisms. The first involves the lysis of infected cells in an 
antigen-specific, HLA-restricted fashion (Yang and Engel, 1993) and the second is a 
suppressive activity that occurs in the absence of cell killing. This non-cytolytic antiviral 
activity is mediated primarily by the release of soluble suppressive factor(s), termed ―CAF‖ 
(CD8 antiviral factor) (Levy et al., 1996; Walker et al., 1986). Seventeen years after the first 
phenomenological description of ―CAF‖, it is becoming increasing clear that no single 
protein can account for all the complex activities documented in different experimental 
systems. Indeed, ―CAF‖ appears to be constituted by numerous factors (Baier et al., 1995; 
Cocchi et al., 1995), some of which are still unknown. 
A wide variety of stimuli have been found to suppress HIV strongly through macrophage 
activation, pointing towards a macrophage-associated antiviral activity. Several results 
corroborate this hypothesis. Urokinase-urokinase receptor interactions (Alfano et al., 2003), 
CD40-CD40L interactions (Cotter et al., 2001; Marzio et al., 2003), stimulation with 
bacterial LPS (Verani et al., 1997) and stimulation through FcR (Perez-Bercoff et al., 
2003), have all been reported to inhibit HIV-1 replication in macrophages. Protection from 
productive infection is frequently mediated by the release of soluble factors. As with 
―CAF‖, macrophage antiviral factor (―MAF‖) appears to be a complex cocktail of different 
proteins (Agace et al., 2000; Agerberth et al., 2000; Cotter et al., 2001; Perez-Bercoff et al., 
2003; Verani et al., 1997). Some of the soluble suppressive factors have been extensively 
studied and coincide with the main component of the ―CAF‖ activity, notably the CCR5-
binding chemokines RANTES, MIP-1 and MIP-1. In addition, several macrophage-
derived cytokines, including type-I interferons (i.e., IFN- and IFN-), MDC, TNF-, IL-
10, and leukemia inhibitory factor (LIF), have been reported to suppress HIV-1 replication, 
at least in some experimental systems. 
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IFN- and - have long been known to inhibit HIV-1 replication by suppressing reverse 
transcription and preventing transcription of the integrated provirus (Honda et al., 1998; 
Kornbluth et al., 1989; Tissot and Mechti, 1995). IL-10 and TNF- have been shown to 
have different effects on HIV replication in macrophages depending on the experimental 
conditions. Indeed, treatment of primary macrophages with IL-10 abrogates HIV-1 infection 
by inhibiting the production of both spliced and unspliced HIV-1 RNA transcripts and by 
interfering with protein processing (Kootstra et al., 1994; Naif et al., 1996). However, 
another study found that IL-10 promotes the productive infection of monocytes by the R5 
virus by selectively upregulating CCR5 and increasing viral entry (Sozzani et al., 1998). 
The effect of TNF-on HIV-1 replication depends on the timing of exposure of 
mononuclear phagocytes to this cytokine. Endogenous TNF- released by infected 
macrophages may protect uninfected monocytes and macrophages from infection with HIV-
1 (by stimulating CCR5 ligand production) (Lane et al., 1999). However, following 
integration of the virus into the cellular genome, the continual production of TNF- may 
enhance HIV-1 replication (Duh et al., 1989; Osborn et al., 1989). MDC is a -chemokine 
purified from the supernatant of immortalised CD8
+
 T cells of HIV-seropositive individuals. 
It has been reported to inhibit different HIV and simian immunodeficiency virus strains 
regardless of their co-receptor usage (Cota et al., 2000; Pal et al., 1997). Nevertheless, the 
inhibitory activity of MDC is still controversial, and the mechanism through which MDC 
inhibits both R5 and X4 isolates also remains elusive (Lee, 1998; Perez-Bercoff et al., 
2003). Finally, LIF, a factor that can be released by CD4
+
 T cells, CD8
+
 T cells (Metcalf et 
al., 1990) and monocytes/macrophages (Anegon et al., 1991), inhibits HIV-1 in a tropism-
independent manner and is produced at higher concentrations in placentae from non-
transmitting HIV-infected women than in placentae from transmitting women (Patterson et 
al., 2001). Nevertheless, others factors undoubtedly constitute another important component 
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of ―MAF‖ activity. This is supported by data on LPS stimulation. Indeed, soluble factor(s) 
released by macrophages upon LPS treatment inhibit infection with X4 viruses in both 
macrophages and T lymphocytes (Verani et al., 2002). HIV-1 suppression is independent of 
SDF-1, the only known natural ligand of CXCR4, and unrelated to the release of IFN-/, 
MDC, LIF or TNF-. Even more importantly, infection of both cell types appears to be 
blocked primarily at the level of viral entry. For this reason, LPS-induced suppressive 
factor(s) appears to be distinct from the as yet unidentified ―CAF‖, which inhibits the 
replication of X4 strains of HIV-1 at the level of viral transcription by suppressing long 
terminal repeat-driven viral expression (Mackewicz et al., 1995). These results reveal the 
existence of potent HIV-1 inhibitory factor(s). These uncharacterised factors are released by 
activated cells of the mononuclear phagocytic system. This suggests that further knowledge 
of the mechanisms of macrophage activation may lead to novel therapeutic and preventive 
strategies for the control of HIV disease. 
Conclusions 
Several lines of evidence show that macrophages play a pivotal role in HIV-1 persistence and 
pathogenesis. Macrophages may serve as sites for virus replication at late stages of AIDS 
when CD4
+
 T cells are markedly depleted or following withdrawal of viral inhibitor 
treatment. Indeed, the presence of persistently infected macrophages in the body represents a 
key challenge for therapeutic efforts to eradicate HIV infection by eliminating all cells 
harbouring the viral genome and/or sustaining virus replication for a long period of time 
(Collman et al., 2003).  
However, the role of macrophages in HIV-1 infection is appearing more complex as the result 
of studies highlighting their potential role in the protection against HIV-1 infection either 
through the production of inhibitory factors or through the direct control of HIV-1 replication. 
Macrophages may also exert neurotrophic and neuroprotective activities in CNS infection. 
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Improvements in our knowledge of the features of viral replication that are peculiar to 
macrophages will provide us with a better understanding of HIV-1 transmission and 
pathogenesis. Furthermore, they may lead to the design of more refined and selective antiviral 
strategies. 
Abbreviations: 
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Figure 1. Peculiar features of HIV-1 replication in macrophages. Differences between the 
HIV-1 life cycle in macrophages and CD4 T cells: - Distinct tropism of HIV-1 isolates: 
inefficient replication of TCLA X4 HIV-1 in macrophages. - Involvement of different surface 
molecules in the binding of HIV-1 to macrophages and alternative entry by macropinocytosis. 
-  PIC nuclear import through an intact nuclear membrane. – Macrophage-specific regulation 
of transcription: role of C/EBPViral assembly and budding in MVB. - Exosomal viral 
exit
FigureA : Perivascular infiltrate of macrophages in an asymptomatic SIVmac251-infected 
macaque. Stained with CD68 mAb. B: high level of EAAT-2 expression in a perivascular 
macrophage in an asymptomatic SIVmac251-infected macaque. Stained with anti-EAAT-2 
polyclonal Abs. C: high level of EAAT-2 expression in a parenchymal microglial cell in an 
asymptomatic SIVmac251-infected macaque. Stained with anti-EAAT-2 polyclonal Abs. 
 
